Literature DB >> 26617864

Clinicopathological significance of CD206-positive macrophages in patients with acute tubulointerstitial disease.

Jun Li1, Chang-Hua Liu1, Dao-Liang Xu1, Bo Gao1.   

Abstract

OBJECTIVE: To investigate the clinicopathological significance of CD206-positive macrophage expression in patients with acute tubulointerstitial disease, including acute tubular necrosis (ATN) and acute interstitial nephritis (AIN).
METHODS: Renal tissue samples from patients with ATN (n=10), AIN (n=10), and minimal change disease (MCD, as disease control, n=8) as well as tissue from normal control kidneys (negative control, n=3) were included in this study. The expression of CD206 and CD68 in renal tissues was detected by immunohistochemistry or immunofluorescence.
RESULTS: CD206-positive cells accumulated in areas around damaged tubular cells and regenerating tubules. Compared with AIN patients, ATN patients had lower serum albumin, lower proteinuria, lower urinary osmolality and higher plasma hemoglobin, (P=0.002; P=0.01; P<0.001; P=0.002, respectively). CD206-positive cells could also be observed in the tubular basement membrane and tubule lumen. Some CD206-positive cells infiltrated into the tubular cells in patients with AIN. Compared to patients with ATN, patients with AIN had more CD206-positive cells (P=0.005). In the ATN patients, there were more CD206-positive cells in ischemic tissue. CD206-positive cells were negatively correlated with hemoglobin (r=-0.565, P=0.009) and positively correlated with serum albumin (r=0.496, P=0.026), urinary osmolality (r=0.567, P=0.009) and proteinuria (r=0.460, P=0.041). There was no correlation between CD206-positive cells and eGFR.
CONCLUSION: CD206-positive macrophages are involved in the pathogenesis of acute tubular necrosis and acute interstitial nephritis.

Entities:  

Keywords:  CD206; acute interstitial nephritis; acute tubular necrosis; macrophage

Mesh:

Substances:

Year:  2015        PMID: 26617864      PMCID: PMC4637680     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor.

Authors:  Senthilkumar Alagesan; Matthew D Griffin
Journal:  Kidney Int       Date:  2014-04       Impact factor: 10.612

2.  Macrophage dynamics in AKI to CKD progression.

Authors:  Gilbert R Kinsey
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

3.  The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.

Authors:  Xiao Chen; Cen-Cen Wang; Shu-Min Song; Shi-Yao Wei; Jian-Si Li; Shi-Lei Zhao; Bing Li
Journal:  J Formos Med Assoc       Date:  2015-02-11       Impact factor: 3.282

4.  Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Authors:  Julie Belliere; Audrey Casemayou; Laure Ducasse; Alexia Zakaroff-Girard; Frédéric Martins; Jason S Iacovoni; Céline Guilbeau-Frugier; Bénédicte Buffin-Meyer; Bernard Pipy; Dominique Chauveau; Joost P Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

5.  Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences.

Authors:  Robert D Stout; Chuancang Jiang; Bharati Matta; Illya Tietzel; Stephanie K Watkins; Jill Suttles
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

Review 6.  Role of the mannose receptor in the immune response.

Authors:  V Apostolopoulos; I F McKenzie
Journal:  Curr Mol Med       Date:  2001-09       Impact factor: 2.222

Review 7.  From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor.

Authors:  Paola Allavena; Marcello Chieppa; Paolo Monti; Lorenzo Piemonti
Journal:  Crit Rev Immunol       Date:  2004       Impact factor: 2.214

8.  Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.

Authors:  Junyu Lu; Qi Cao; Dong Zheng; Yan Sun; Changqi Wang; Xiao Yu; Ya Wang; Vincent W S Lee; Guoping Zheng; Thian K Tan; Xin Wang; Stephen I Alexander; David C H Harris; Yiping Wang
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

9.  Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy.

Authors:  Maciej Lech; Regina Gröbmayr; Mi Ryu; Georg Lorenz; Ingo Hartter; Shrikant R Mulay; Heni Eka Susanti; Koichi S Kobayashi; Richard A Flavell; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

10.  Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages.

Authors:  Yanqiu Geng; Li Zhang; Bo Fu; Jianrong Zhang; Quan Hong; Jie Hu; Diangeng Li; Congjuan Luo; Shaoyuan Cui; Fei Zhu; Xiangmei Chen
Journal:  Stem Cell Res Ther       Date:  2014-06-24       Impact factor: 6.832

View more
  5 in total

Review 1.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

2.  Shroom3, a Gene Associated with CKD, Modulates Epithelial Recovery after AKI.

Authors:  Aihua Li; Joanna Cunanan; Hadiseh Khalili; Timothy Plageman; Kjetil Ask; Ahsan Khan; Ashmeet Hunjan; Thomas Drysdale; Darren Bridgewater
Journal:  Kidney360       Date:  2021-11-03

3.  Pericoronary Adipose Tissue as Storage and Supply Site for Oxidized Low-Density Lipoprotein in Human Coronary Plaques.

Authors:  Yasumi Uchida; Yasuto Uchida; Ei Shimoyama; Nobuyuki Hiruta; Toshihiko Kishimoto; Soichiro Watanabe
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

4.  Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren's disease.

Authors:  Jun Li; Ya-Fen Yu; Chang-Hua Liu; Cui-Mei Wang
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

5.  Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy.

Authors:  Jie Hou; Manli Zhang; Yuhong Ding; Xinrui Wang; Tao Li; Pujun Gao; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2018-06-21       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.